News

Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...
Madrigal Pharmaceuticals beat Q1 sales estimates with Rezdiffra, and catalysts like EU approval and pipeline plans add upside ...
Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...
Wall Street cruised to the finish of its strong week on Friday, as U.S. stocks glided closer to the all-time high they set ...
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...
To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.
NBC News and MSNBC medical contributor Dr. Kavita Patel joins ‘Fast Money’ to discuss Novo Nordisk after the company ousted ...
U.S. stocks are set to wrap a winning week as tariff and trade fears ease, President Trump winds down his Middle East trip securing billions of investments for the U.S. and Warren Buffett’s Berkshire ...
A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX) stock ...